The treatment for maternal supraventricular tachyarrhythmia in pregnant patients in ED practice
Acute supraventricular tachyarrhythmia (ASVT) in pregnancy is a very important problem because it impairs maternal and fetal blood circulation. [...]the treatment of ASVT should be planned more carefully in the pregnant woman [2] . Intravenous adenosine therapy is in Food and Drug Administration (FD...
Gespeichert in:
| Veröffentlicht in: | The American journal of emergency medicine 2016-08, Vol.34 (8), p.1702-1704 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1704 |
|---|---|
| container_issue | 8 |
| container_start_page | 1702 |
| container_title | The American journal of emergency medicine |
| container_volume | 34 |
| creator | Saricam, Ersin Mutlu, Mehmet Fırat Ozkan, Mustafa Barindik, Nadir |
| description | Acute supraventricular tachyarrhythmia (ASVT) in pregnancy is a very important problem because it impairs maternal and fetal blood circulation. [...]the treatment of ASVT should be planned more carefully in the pregnant woman [2] . Intravenous adenosine therapy is in Food and Drug Administration (FDA) pregnancy category C. Animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans [5] . Because of limited human data, antiarrhythmic therapy in pregnant women should usually be performed carefully with as low pharmacological doses as possible [6] . |
| doi_str_mv | 10.1016/j.ajem.2016.05.049 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1807081742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735675716301826</els_id><sourcerecordid>1807081742</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-7353460de8b5f9220cd25ae23f86b0c77608b4bb9850843a66957c68888579243</originalsourceid><addsrcrecordid>eNp9kD1v1TAUhi0EopfCH2BAkVhYkh47_orEgkoLlSqxlNlynBOuo3xhO5Xuv8fRbRkY8GLr1fMeHT-EvKdQUaDyaqjsgFPF8rsCUQFvXpADFTUrNVX0JTmAqkUplVAX5E2MAwClXPDX5IIpxqmQ6kDMwxGLFNCmCedU9EsoJpswzHYs4rYG-5jj4N022lAk644nG8LxlI6Tt4WfizXgr9nm5mqTz2jcw5uvObcueYdvyavejhHfPd2X5OftzcP19_L-x7e76y_3pas1T2VetOYSOtSt6BvGwHVMWGR1r2ULTikJuuVt22gBmtdWykYoJ3U-QjWM15fk03nuGpbfG8ZkJh8djqOdcdmioRoUZC2cZfTjP-iwbPuHz1SjADRkip0pF5YYA_ZmDX6y4WQomF2_Gcyu3-z6DQiT9efSh6fRWzth97fy7DsDn88AZhePHoOJLmtz2PmALplu8f-b_wcdlpVr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1807970080</pqid></control><display><type>article</type><title>The treatment for maternal supraventricular tachyarrhythmia in pregnant patients in ED practice</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Saricam, Ersin ; Mutlu, Mehmet Fırat ; Ozkan, Mustafa ; Barindik, Nadir</creator><creatorcontrib>Saricam, Ersin ; Mutlu, Mehmet Fırat ; Ozkan, Mustafa ; Barindik, Nadir</creatorcontrib><description>Acute supraventricular tachyarrhythmia (ASVT) in pregnancy is a very important problem because it impairs maternal and fetal blood circulation. [...]the treatment of ASVT should be planned more carefully in the pregnant woman [2] . Intravenous adenosine therapy is in Food and Drug Administration (FDA) pregnancy category C. Animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans [5] . Because of limited human data, antiarrhythmic therapy in pregnant women should usually be performed carefully with as low pharmacological doses as possible [6] .</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/j.ajem.2016.05.049</identifier><identifier>PMID: 27241567</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenosine ; Adult ; Anti-Arrhythmia Agents - therapeutic use ; Cardiac arrhythmia ; Cardiology ; Catheters ; Drug therapy ; Electrocardiography ; Emergency medical care ; Emergency Service, Hospital ; Female ; Fetuses ; Heart rate ; Humans ; Pain ; Pregnancy ; Pregnancy Complications, Cardiovascular ; Tachycardia, Supraventricular - drug therapy ; Young Adult</subject><ispartof>The American journal of emergency medicine, 2016-08, Vol.34 (8), p.1702-1704</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright Elsevier Limited 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-7353460de8b5f9220cd25ae23f86b0c77608b4bb9850843a66957c68888579243</citedby><cites>FETCH-LOGICAL-c384t-7353460de8b5f9220cd25ae23f86b0c77608b4bb9850843a66957c68888579243</cites><orcidid>0000-0002-8736-1786</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1807970080?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27241567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saricam, Ersin</creatorcontrib><creatorcontrib>Mutlu, Mehmet Fırat</creatorcontrib><creatorcontrib>Ozkan, Mustafa</creatorcontrib><creatorcontrib>Barindik, Nadir</creatorcontrib><title>The treatment for maternal supraventricular tachyarrhythmia in pregnant patients in ED practice</title><title>The American journal of emergency medicine</title><addtitle>Am J Emerg Med</addtitle><description>Acute supraventricular tachyarrhythmia (ASVT) in pregnancy is a very important problem because it impairs maternal and fetal blood circulation. [...]the treatment of ASVT should be planned more carefully in the pregnant woman [2] . Intravenous adenosine therapy is in Food and Drug Administration (FDA) pregnancy category C. Animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans [5] . Because of limited human data, antiarrhythmic therapy in pregnant women should usually be performed carefully with as low pharmacological doses as possible [6] .</description><subject>Adenosine</subject><subject>Adult</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Catheters</subject><subject>Drug therapy</subject><subject>Electrocardiography</subject><subject>Emergency medical care</subject><subject>Emergency Service, Hospital</subject><subject>Female</subject><subject>Fetuses</subject><subject>Heart rate</subject><subject>Humans</subject><subject>Pain</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Cardiovascular</subject><subject>Tachycardia, Supraventricular - drug therapy</subject><subject>Young Adult</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kD1v1TAUhi0EopfCH2BAkVhYkh47_orEgkoLlSqxlNlynBOuo3xhO5Xuv8fRbRkY8GLr1fMeHT-EvKdQUaDyaqjsgFPF8rsCUQFvXpADFTUrNVX0JTmAqkUplVAX5E2MAwClXPDX5IIpxqmQ6kDMwxGLFNCmCedU9EsoJpswzHYs4rYG-5jj4N022lAk644nG8LxlI6Tt4WfizXgr9nm5mqTz2jcw5uvObcueYdvyavejhHfPd2X5OftzcP19_L-x7e76y_3pas1T2VetOYSOtSt6BvGwHVMWGR1r2ULTikJuuVt22gBmtdWykYoJ3U-QjWM15fk03nuGpbfG8ZkJh8djqOdcdmioRoUZC2cZfTjP-iwbPuHz1SjADRkip0pF5YYA_ZmDX6y4WQomF2_Gcyu3-z6DQiT9efSh6fRWzth97fy7DsDn88AZhePHoOJLmtz2PmALplu8f-b_wcdlpVr</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>Saricam, Ersin</creator><creator>Mutlu, Mehmet Fırat</creator><creator>Ozkan, Mustafa</creator><creator>Barindik, Nadir</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8736-1786</orcidid></search><sort><creationdate>201608</creationdate><title>The treatment for maternal supraventricular tachyarrhythmia in pregnant patients in ED practice</title><author>Saricam, Ersin ; Mutlu, Mehmet Fırat ; Ozkan, Mustafa ; Barindik, Nadir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-7353460de8b5f9220cd25ae23f86b0c77608b4bb9850843a66957c68888579243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenosine</topic><topic>Adult</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Catheters</topic><topic>Drug therapy</topic><topic>Electrocardiography</topic><topic>Emergency medical care</topic><topic>Emergency Service, Hospital</topic><topic>Female</topic><topic>Fetuses</topic><topic>Heart rate</topic><topic>Humans</topic><topic>Pain</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Cardiovascular</topic><topic>Tachycardia, Supraventricular - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saricam, Ersin</creatorcontrib><creatorcontrib>Mutlu, Mehmet Fırat</creatorcontrib><creatorcontrib>Ozkan, Mustafa</creatorcontrib><creatorcontrib>Barindik, Nadir</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saricam, Ersin</au><au>Mutlu, Mehmet Fırat</au><au>Ozkan, Mustafa</au><au>Barindik, Nadir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The treatment for maternal supraventricular tachyarrhythmia in pregnant patients in ED practice</atitle><jtitle>The American journal of emergency medicine</jtitle><addtitle>Am J Emerg Med</addtitle><date>2016-08</date><risdate>2016</risdate><volume>34</volume><issue>8</issue><spage>1702</spage><epage>1704</epage><pages>1702-1704</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><abstract>Acute supraventricular tachyarrhythmia (ASVT) in pregnancy is a very important problem because it impairs maternal and fetal blood circulation. [...]the treatment of ASVT should be planned more carefully in the pregnant woman [2] . Intravenous adenosine therapy is in Food and Drug Administration (FDA) pregnancy category C. Animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans [5] . Because of limited human data, antiarrhythmic therapy in pregnant women should usually be performed carefully with as low pharmacological doses as possible [6] .</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27241567</pmid><doi>10.1016/j.ajem.2016.05.049</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-8736-1786</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-6757 |
| ispartof | The American journal of emergency medicine, 2016-08, Vol.34 (8), p.1702-1704 |
| issn | 0735-6757 1532-8171 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1807081742 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Adenosine Adult Anti-Arrhythmia Agents - therapeutic use Cardiac arrhythmia Cardiology Catheters Drug therapy Electrocardiography Emergency medical care Emergency Service, Hospital Female Fetuses Heart rate Humans Pain Pregnancy Pregnancy Complications, Cardiovascular Tachycardia, Supraventricular - drug therapy Young Adult |
| title | The treatment for maternal supraventricular tachyarrhythmia in pregnant patients in ED practice |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A59%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20treatment%20for%20maternal%20supraventricular%20tachyarrhythmia%20in%20pregnant%20patients%20in%20ED%20practice&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Saricam,%20Ersin&rft.date=2016-08&rft.volume=34&rft.issue=8&rft.spage=1702&rft.epage=1704&rft.pages=1702-1704&rft.issn=0735-6757&rft.eissn=1532-8171&rft_id=info:doi/10.1016/j.ajem.2016.05.049&rft_dat=%3Cproquest_cross%3E1807081742%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1807970080&rft_id=info:pmid/27241567&rft_els_id=S0735675716301826&rfr_iscdi=true |